Summary
- Current Price
- As of today, PEN price is $327.59, up +0.26% in the most recent trading session on
- Current Price All-Time High
- PEN price is currently -9.61% below its historical high of $362.41 set on
- Market Cap
- PEN current market cap is $13B, up +30.76% over the past 365 days
- PE Ratio
- PEN current PE ratio is 80.45
- Revenue
- PEN current annual revenue is $1.40B, up +17.50% year-over-year
- Next Earnings
- The next earnings release for PEN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Penumbra, Inc. |
| Ticker | NYSE: PEN |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | penumbrainc.com |
| Employees | 4,500 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $327.59 | |
| Price, 1D Change | +0.26% | |
| Market Cap | $13B | |
| - | ||
| PE Ratio | 80.45 | |
| Beta | 0.09 | |
| Revenue | $1.40B | |
| Revenue, 1Y Change | +17.50% | |
| EPS | $4.52 | |
| EPS, 1Y Change | +1,167.43% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $4.52 | |
| EPS Estimate | $4.60 | N/A |
| EPS Est. Change | +1.70% | N/A |
| Revenue | $1.40B | |
| Revenue Estimate | $1.60B | N/A |
| Revenue Est. Change | +13.65% | N/A |
| Current Price | $327.59 | |
| Price Target | $374.00 | - |
| Price Tgt. Change | +14.17% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.78 | $0.36 | -87.19% | |
| $3.78 | $4.52 | +19.51% | |
| $4.60 | N/A | +1.70% | |
| $6.13 | N/A | +35.60% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.19B | $1.19B | +0.34% | |
| $1.38B | $1.40B | +1.39% | |
| $1.60B | N/A | +13.65% | |
| $1.80B | N/A | +28.22% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +29.37% | |
| Price, 3Y | +28.15% | |
| Market Cap, 1Y | +30.76% | |
| Market Cap, 3Y | +31.43% | |
| Revenue, 1Y | +17.50% | |
| Revenue, 3Y | +65.70% | |
| EPS, 1Y | +1,167.43% | |
| EPS, 3Y | +8,648.58% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $327.59 | |
| SMA 200 | $318.56 | |
| SMA 50 | $319.31 | |
| EMA 200 | $313.09 | |
| EMA 50 | $321.34 | |
| MACD | $2.04 | |
| Beta | 0.09 | |
| ATR | $2.17 | |
| 14-Day RSI | 71.34 | |
| 10-Day Volatility | 4.71% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $1.40B | |
| EPS | $4.52 | |
| Gross Profit | $0.00 | |
| Gross Margin | 65.66% | |
| Operating Income | $189.25M | |
| Operating Margin | 13.48% | |
| Net Income | $177.69M | |
| Net Margin | 12.66% | |
| EBITDA | $206.72M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.15 | |
| 6.64 | ||
| 4.29 | ||
| - | ||
| 6 | ||
| 21.38 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 80.45 | |
| 8.57 | ||
| 8.43 | ||
| 60.92 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $1.43B | |
| $544.82M | ||
| $1.83B | ||
| $1.22B | ||
| $398.92M | ||
| $183.13M | ||
| Total Debt | $219.70M | |
| $16.23M | ||
| $34.74M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $1.23B | ||
| $732.40M | ||
| $461.23M | ||
| $0.00 | ||
| $17.47M | ||
| $0.00 | ||
| $27.44M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $238.66M | ||
| -$404.59M | ||
| $26.53M | ||
| Capex | $63.73M | |
| $174.93M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Evercore ISI Group | → | |
| RBC Capital | → | |
| Evercore ISI Group | → | |
| Citigroup | → | |
| Evercore ISI Group | → | |
| RBC Capital | → | |
| Canaccord Genuity | → | |
| Truist Securities | → | |
| Needham | → | |
| Leerink Partners | → |
Analyst sentiment
Institutional ownership
Screeners with PEN
FAQ
- What is the ticker symbol for Penumbra, Inc.?
- The ticker symbol for Penumbra, Inc. is NYSE:PEN
- Does Penumbra, Inc. pay dividends?
- No, Penumbra, Inc. does not pay dividends
- What sector is Penumbra, Inc. in?
- Penumbra, Inc. is in the Healthcare sector
- What industry is Penumbra, Inc. in?
- Penumbra, Inc. is in the Medical Devices industry
- What country is Penumbra, Inc. based in?
- Penumbra, Inc. is headquartered in United States
- When did Penumbra, Inc. go public?
- Penumbra, Inc. initial public offering (IPO) was on September 18, 2015
- Is Penumbra, Inc. in the S&P 500?
- No, Penumbra, Inc. is not included in the S&P 500 index
- Is Penumbra, Inc. in the NASDAQ 100?
- No, Penumbra, Inc. is not included in the NASDAQ 100 index
- Is Penumbra, Inc. in the Dow Jones?
- No, Penumbra, Inc. is not included in the Dow Jones index
- When was Penumbra, Inc. last earnings report?
- Penumbra, Inc.'s most recent earnings report was on July 30, 2026
- When does Penumbra, Inc. report earnings?
- The next expected earnings date for Penumbra, Inc. is November 4, 2026
Data Sources & References
- PEN Official Website www.penumbrainc.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1321732/000132173226000007/0001321732-26-000007-index.htm
- PEN Profile on Yahoo Finance finance.yahoo.com/quote/PEN
- PEN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pen
